The "Hypoglycemic Drugs Market," according to Introspective Market Research says that a detailing significant Global expansion fueled by the escalating prevalence of diabetes and the revolutionary shift toward advanced therapeutic options that offer multi-organ benefits. The report projects that the global market, valued at an estimated $61.21 Billion  in 2023, is forecasted to...